Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa
- PMID: 33575982
- DOI: 10.1007/s40519-021-01106-7
Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa
Abstract
Purpose: The endocannabinoid system plays a key role in eating behavior regulating appetite and reward mechanisms, but the impact of its genetic variability has been scarcely studied in Anorexia Nervosa (AN). We aimed to analyze the association of genetic variants in cannabinoid receptors with the risk for AN and with psychiatric comorbidities that are commonplace in these patients.
Methods: We screened 221 AN patients and 396 controls for 14 tag-SNPs in the CNR1 and CNR2 genes, coding for cannabinoids receptors CB1 and CB2, respectively. Patients were diagnosed according to DSM-5 criteria and interviewed with the SCL-90R and the EDI-2 inventories to identify AN-coupled and general psychopathology.
Results: None of the tag-SNPs was significantly related to AN risk. However, the rs806369-TT genotype and haplotype rs806368/rs1049353/rs806369 of CNR1 were respectively associated with lower weight (mean difference = - 4.92 kg, FDR-q = 0.044) and BMI (FDR-q = 0.042) in AN patients. CNR1 rs806374-TT and CNR2 rs3003335-AA and rs6658703-GG genotypes correlated with higher scores in the Positive Symptom Distress Index (PSDI, FDR-q = 0.011 and 0.009, respectively). These three genotypes were also linked to increased Hostility in the patients (FDR-q < 0.05). Remarkably, a proximal area of the CNR1 gene locus (positions 88,143,916-88,149,832) correlated with PSDI, Hostility, Asceticism and EDI-2 total scores after correcting by multiple testing (FDR-q < 0.05 in all instances). Finally, significant CNR1/CNR2 epistasis was observed in relation to Hostility (p < 0.01) and Maturity Fears (p < 0.001).
Conclusion: The CNR1 and CNR2 genes, coding for cannabinoid receptors, may constitute important loci regarding psychiatric comorbidities in AN patients.
Level iii: Evidence obtained from well-designed cohort or case-control analytic studies.
Keywords: Anorexia nervosa; CNR1; CNR2; Cannabinoid receptors; Comorbidities.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature.
Similar articles
-
Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.J Clin Med. 2024 Sep 1;13(17):5189. doi: 10.3390/jcm13175189. J Clin Med. 2024. PMID: 39274402 Free PMC article.
-
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.Genes Brain Behav. 2009 Oct;8(7):728-32. doi: 10.1111/j.1601-183X.2009.00518.x. Epub 2009 Jun 26. Genes Brain Behav. 2009. PMID: 19659925
-
Variants in the Obesity-Linked FTO gene locus modulates psychopathological features of patients with Anorexia Nervosa.Gene. 2021 May 30;783:145572. doi: 10.1016/j.gene.2021.145572. Epub 2021 Mar 16. Gene. 2021. PMID: 33737121
-
Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.Int Rev Neurobiol. 2009;88:335-69. doi: 10.1016/S0074-7742(09)88012-4. Int Rev Neurobiol. 2009. PMID: 19897083 Review.
-
Genetic polymorphisms of the endocannabinoid system in obesity and diabetes.Diabetes Obes Metab. 2019 Feb;21(2):382-387. doi: 10.1111/dom.13504. Epub 2018 Sep 16. Diabetes Obes Metab. 2019. PMID: 30129173
Cited by
-
Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population.Front Nutr. 2022 Mar 14;9:838177. doi: 10.3389/fnut.2022.838177. eCollection 2022. Front Nutr. 2022. PMID: 35369087 Free PMC article.
-
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.Int J Mol Sci. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764. Int J Mol Sci. 2022. PMID: 35563156 Free PMC article. Review.
-
Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.J Clin Med. 2024 Sep 1;13(17):5189. doi: 10.3390/jcm13175189. J Clin Med. 2024. PMID: 39274402 Free PMC article.
-
Inclusion of the severe and enduring anorexia nervosa phenotype in genetics research: a scoping review.J Eat Disord. 2024 Apr 29;12(1):53. doi: 10.1186/s40337-024-01009-9. J Eat Disord. 2024. PMID: 38685102 Free PMC article.
-
Pharmacotherapeutic strategies for the treatment of anorexia nervosa - novel targets to break a vicious cycle.Expert Opin Pharmacother. 2024 Dec;25(17):2253-2265. doi: 10.1080/14656566.2024.2424316. Epub 2024 Nov 5. Expert Opin Pharmacother. 2024. PMID: 39497232 Free PMC article. Review.
References
-
- Mendolicchio L, Maggio G, Fortunato F, Ragione LD (2014) Update on eating disorders: epidemiology, mortality and comorbidity. Psychiatr Danub 26(Suppl 1):85–88 - PubMed
-
- Atiye M, Miettunen J, Raevuori-Helkamaa A (2015) A meta-analysis of temperament in eating disorders. Eur Eat Disord Rev 23:89–99. https://doi.org/10.1002/erv.2342 - DOI - PubMed
-
- Lilenfeld LR (2011) Personality and temperament. Curr Top Behav Neurosci 6:3–16. https://doi.org/10.1007/7854_2010_86 - DOI - PubMed
-
- Monteleone P, Maj M (2008) Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics 9:1487–1520 - DOI
-
- Gorwood P, Kipman A, Foulon C (2003) The human genetics of anorexia nervosa. Eur J Pharmacol 480:163–170 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous